| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | negative regulation of non-motile cilium assembly | 1.52e-07 | 3 | 111 | 3 | GO:1902856 | |
| GeneOntologyBiologicalProcess | positive regulation of chromosome separation | 2.23e-05 | 31 | 111 | 4 | GO:1905820 | |
| GeneOntologyBiologicalProcess | regulation of DNA-templated DNA replication initiation | 6.58e-05 | 15 | 111 | 3 | GO:0030174 | |
| Domain | Tankyrase-bd_C | 3.50e-05 | 2 | 111 | 2 | IPR032764 | |
| Domain | Tankyrase_bdg_C | 3.50e-05 | 2 | 111 | 2 | SM01319 | |
| Domain | Tankyrase_bdg_C | 3.50e-05 | 2 | 111 | 2 | PF15327 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | PCNP TTF2 ZNF384 FAM193B EXOSC10 MAP4 MYO6 DLGAP5 MCM4 OCRL NCAPH XAB2 KIAA1671 ALDH1A2 AHNAK CYB5R3 TNKS1BP1 BOD1L1 STIP1 AFF4 DNM2 | 2.33e-12 | 934 | 112 | 21 | 33916271 |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | TTF2 EXOSC10 DOCK8 WRNIP1 SMC2 ARID1A NCAPH FAF1 AHNAK TNKS1BP1 DIAPH3 TRMT1L DNM2 AURKB | 6.18e-09 | 582 | 112 | 14 | 20467437 |
| Pubmed | PCNP TTF2 EXOSC10 MAP4 SMC2 ARID1A NCAPH KIAA1671 AHNAK TNKS1BP1 BOD1L1 DIAPH3 | 2.24e-07 | 549 | 112 | 12 | 38280479 | |
| Pubmed | PCNP MCM4 SMC2 ARID1A NCAPH AHNAK TNKS1BP1 BOD1L1 TRMT1L AURKB PTCD3 | 3.69e-07 | 469 | 112 | 11 | 27634302 | |
| Pubmed | TTF2 MAP4 MYO6 MCM4 OCRL SMC2 AHNAK CYB5R3 TNKS1BP1 BOD1L1 STIP1 HADHA DIAPH3 | 4.95e-07 | 708 | 112 | 13 | 39231216 | |
| Pubmed | Condensin association with histone H2A shapes mitotic chromosomes. | 1.13e-06 | 7 | 112 | 3 | 21633354 | |
| Pubmed | 1.16e-06 | 57 | 112 | 5 | 38223760 | ||
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 1.37e-06 | 332 | 112 | 9 | 32786267 | |
| Pubmed | COG2 EXOSC10 MAP4 MYO6 WRNIP1 MCM4 SMC2 XAB2 HADHA DNM2 PTCD3 | 2.07e-06 | 560 | 112 | 11 | 35241646 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 3.98e-06 | 283 | 112 | 8 | 30585729 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | DHX16 TTF2 ZNF384 EXOSC10 MAP4 MYO6 DLGAP5 MCM4 OCRL SMC2 ARID1A NCAPH AHNAK HADHA DDX60L PTCD3 | 7.13e-06 | 1353 | 112 | 16 | 29467282 |
| Pubmed | DHX16 EXOSC10 MAP4 MCM4 ARID1A XAB2 AHNAK TNKS1BP1 HADHA DNM2 PTCD3 | 8.88e-06 | 653 | 112 | 11 | 22586326 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 24081861 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 32495484 | ||
| Pubmed | [From gene to disease; Dent's disease caused by abnormalities in the CLCN5 and OCRL1 genes]. | 1.03e-05 | 2 | 112 | 2 | 18019214 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 27174143 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 22876375 | ||
| Pubmed | Clinical features and genetic analysis of 15 Chinese children with dent disease. | 1.03e-05 | 2 | 112 | 2 | 38726999 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 31674016 | ||
| Pubmed | Aurora B regulates formin mDia3 in achieving metaphase chromosome alignment. | 1.03e-05 | 2 | 112 | 2 | 21397845 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | DHX16 EXOSC10 MAP4 MYO6 ZFC3H1 SMC2 NCAPH XAB2 KIAA1671 AHNAK TNKS1BP1 HADHA TRMT1L AURKB PTCD3 | 1.27e-05 | 1257 | 112 | 15 | 36526897 |
| Pubmed | PCNP TTF2 ZNF384 EXOSC10 MAP4 DOCK8 GPS2 WRNIP1 MCM4 SMC2 ARID1A ELF1 HADHA DNM2 | 1.28e-05 | 1103 | 112 | 14 | 34189442 | |
| Pubmed | 1.48e-05 | 339 | 112 | 8 | 30415952 | ||
| Pubmed | ZFC3H1 STOX1 PDE10A SMC2 ARID1A STK31 NCAPH CLCN5 STARD9 AHNAK CTAGE1 CYB5R3 BOD1L1 HADHA JAKMIP1 DIAPH3 | 1.57e-05 | 1442 | 112 | 16 | 35575683 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | FKBP10 EXOSC10 MAP4 MYO6 MCM4 SMC2 NCAPH FAF1 AHNAK STIP1 HADHA TRMT1L DNM2 PTCD3 | 2.02e-05 | 1149 | 112 | 14 | 35446349 |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 2.02e-05 | 256 | 112 | 7 | 33397691 | |
| Pubmed | DHX16 PCNP EXOSC10 MAP4 WRNIP1 MCM4 SMC2 NCAPH XAB2 AHNAK BOD1L1 TRMT1L AURKB | 2.41e-05 | 1014 | 112 | 13 | 32416067 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | TICRR STOX1 TMEM132B KIAA1671 FREM2 AHNAK BOD1L1 STIP1 IGSF9B HADHA JAKMIP1 | 2.68e-05 | 736 | 112 | 11 | 29676528 |
| Pubmed | An alternative mechanism of clathrin-coated pit closure revealed by ion conductance microscopy. | 3.08e-05 | 3 | 112 | 2 | 22564416 | |
| Pubmed | 3.08e-05 | 3 | 112 | 2 | 28671819 | ||
| Pubmed | 3.08e-05 | 3 | 112 | 2 | 30590522 | ||
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | 3.51e-05 | 498 | 112 | 9 | 36634849 | |
| Pubmed | EXOSC10 MYO6 OCRL NCAPH KIAA1671 LIPE PLEKHM2 AHNAK CYB5R3 CLSPN PTCD3 | 4.37e-05 | 777 | 112 | 11 | 35844135 | |
| Pubmed | 4.71e-05 | 399 | 112 | 8 | 37536630 | ||
| Pubmed | 5.16e-05 | 653 | 112 | 10 | 33742100 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ZNF384 FAM193B PIEZO1 ATG2A ARID1A ZNF263 PLEKHM2 NAPRT AHNAK DEF6 ANKRD11 KCNQ2 TNKS1BP1 | 5.82e-05 | 1105 | 112 | 13 | 35748872 |
| Pubmed | The Chromatin Remodeling Component Arid1a Is a Suppressor of Spontaneous Mammary Tumors in Mice. | 6.14e-05 | 4 | 112 | 2 | 27280691 | |
| Pubmed | 6.14e-05 | 4 | 112 | 2 | 15240869 | ||
| Pubmed | Replication and exploratory analysis of 24 candidate risk polymorphisms for neural tube defects. | 6.14e-05 | 4 | 112 | 2 | 25293959 | |
| Pubmed | Mutational analysis of CLC-5, cofilin and CLC-4 in patients with Dent's disease. | 6.14e-05 | 4 | 112 | 2 | 19546591 | |
| Pubmed | 6.14e-05 | 4 | 112 | 2 | 27126587 | ||
| Pubmed | COG2 MYO6 ZFC3H1 HUNK ARID1A FAF1 XAB2 WDR19 CLK1 VPS35L KCNQ2 JAKMIP1 AFF4 DNM2 | 6.77e-05 | 1285 | 112 | 14 | 35914814 | |
| Pubmed | DHX16 FKBP10 DLGAP5 XAB2 NAPRT AHNAK TNKS1BP1 BOD1L1 STIP1 HADHA DIAPH3 TRMT1L DNM2 AURKB | 7.47e-05 | 1297 | 112 | 14 | 33545068 | |
| Pubmed | ATRX promotes heterochromatin formation to protect cells from G-quadruplex DNA-mediated stress. | 8.01e-05 | 26 | 112 | 3 | 34162889 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | EXOSC10 DLGAP5 WRNIP1 MCM4 XAB2 AHNAK BOD1L1 HADHA CLSPN AFF4 AURKB PTCD3 | 8.52e-05 | 989 | 112 | 12 | 36424410 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ABAT MAP4 MYO6 SOBP ANKMY1 PDE10A ARID1A FAF1 KIAA1671 VPS35L ANKRD11 BOD1L1 IGSF9B PAN3 AFF4 | 8.81e-05 | 1489 | 112 | 15 | 28611215 |
| Pubmed | 9.05e-05 | 224 | 112 | 6 | 32941674 | ||
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | PCNP TTF2 EXOSC10 MYO6 MCM4 SMC2 ARID1A NCAPH BOD1L1 DNM2 PTCD3 | 9.43e-05 | 847 | 112 | 11 | 35235311 |
| Pubmed | 9.73e-05 | 227 | 112 | 6 | 26410627 | ||
| Pubmed | 9.86e-05 | 74 | 112 | 4 | 35102251 | ||
| Pubmed | 1.02e-04 | 5 | 112 | 2 | 12887926 | ||
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | 1.21e-04 | 724 | 112 | 10 | 36232890 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 1.23e-04 | 341 | 112 | 7 | 32971831 | |
| Pubmed | LRF maintains genome integrity by regulating the non-homologous end joining pathway of DNA repair. | 1.27e-04 | 79 | 112 | 4 | 26446488 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | PABIR1 DHX16 TTF2 GPS2 WRNIP1 OCRL ATG2A TNKS1BP1 DIAPH3 PAN3 CLSPN AURKB | 1.34e-04 | 1038 | 112 | 12 | 26673895 |
| Pubmed | Chromosome condensation by a human condensin complex in Xenopus egg extracts. | 1.53e-04 | 6 | 112 | 2 | 11136719 | |
| Pubmed | 1.53e-04 | 6 | 112 | 2 | 18579736 | ||
| Pubmed | 1.56e-04 | 606 | 112 | 9 | 36538041 | ||
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | 1.62e-04 | 477 | 112 | 8 | 31300519 | |
| Pubmed | 1.71e-04 | 481 | 112 | 8 | 28190767 | ||
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | 1.83e-04 | 486 | 112 | 8 | 30940648 | |
| Pubmed | MAP4 MYO6 GPS2 MCM4 SMC2 ARID1A WDR87 TNKS1BP1 STIP1 HADHA TRMT1L AFF4 DNM2 | 1.93e-04 | 1247 | 112 | 13 | 27684187 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | DHX16 EXOSC10 APLP2 ARID1A XAB2 CLK1 CYB5R3 TNKS1BP1 HADHA PAN3 AFF4 PTCD3 | 1.97e-04 | 1082 | 112 | 12 | 38697112 |
| Pubmed | MYO6 SOBP GPS2 ARID1A ZNF691 KIAA1671 ZFHX4 CYB5R3 ELF1 STIP1 HADHA TRMT1L PAN3 PTCD3 | 2.05e-04 | 1429 | 112 | 14 | 35140242 | |
| Pubmed | 2.14e-04 | 7 | 112 | 2 | 16962269 | ||
| Pubmed | 2.14e-04 | 7 | 112 | 2 | 24435047 | ||
| Pubmed | A novel histone deacetylase pathway regulates mitosis by modulating Aurora B kinase activity. | 2.14e-04 | 7 | 112 | 2 | 16980585 | |
| Pubmed | 2.14e-04 | 7 | 112 | 2 | 36717601 | ||
| Pubmed | YY1 controls Igκ repertoire and B-cell development, and localizes with condensin on the Igκ locus. | 2.14e-04 | 7 | 112 | 2 | 23531880 | |
| Pubmed | 2.15e-04 | 36 | 112 | 3 | 33230114 | ||
| Pubmed | COG2 EXOSC10 SMC2 NCAPH KIAA1671 AHNAK VPS35L TNKS1BP1 STIP1 IFI44L HADHA DDX60L TRMT1L PTCD3 | 2.22e-04 | 1440 | 112 | 14 | 30833792 | |
| Pubmed | 2.29e-04 | 638 | 112 | 9 | 33239621 | ||
| Pubmed | 2.39e-04 | 268 | 112 | 6 | 33640491 | ||
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | 2.54e-04 | 271 | 112 | 6 | 32433965 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | ZNF384 EXOSC10 MAP4 DLGAP5 MCM4 ARID1A XAB2 AHNAK ANKRD11 BOD1L1 AFF4 | 2.64e-04 | 954 | 112 | 11 | 36373674 |
| Pubmed | 2.84e-04 | 8 | 112 | 2 | 14532007 | ||
| Pubmed | Reconstitution and subunit geometry of human condensin complexes. | 2.84e-04 | 8 | 112 | 2 | 17268547 | |
| Pubmed | Overlapping and non-overlapping functions of condensins I and II in neural stem cell divisions. | 2.84e-04 | 8 | 112 | 2 | 25474630 | |
| Pubmed | RECQ1 helicase is involved in replication stress survival and drug resistance in multiple myeloma. | 3.25e-04 | 183 | 112 | 5 | 28186131 | |
| Pubmed | 3.40e-04 | 102 | 112 | 4 | 14759258 | ||
| Pubmed | 3.65e-04 | 9 | 112 | 2 | 23110726 | ||
| Pubmed | Mechanistic insights into COVID-19 by global analysis of the SARS-CoV-2 3CLpro substrate degradome. | 3.65e-04 | 43 | 112 | 3 | 34672947 | |
| Pubmed | 3.91e-04 | 44 | 112 | 3 | 25010285 | ||
| Pubmed | EXOSC10 MYO6 DOCK8 WRNIP1 MCM4 APLP2 NCAPH XAB2 CLCN5 AHNAK DEF6 CYB5R3 | 3.93e-04 | 1168 | 112 | 12 | 19946888 | |
| Pubmed | Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. | 4.30e-04 | 552 | 112 | 8 | 10737800 | |
| Pubmed | Condensins I and II are essential for construction of bivalent chromosomes in mouse oocytes. | 4.55e-04 | 10 | 112 | 2 | 21795393 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | 4.62e-04 | 857 | 112 | 10 | 25609649 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | PCNP FKBP10 ZNF384 MAP4 SMC2 ARID1A NCAPH FAF1 XAB2 AHNAK CYB5R3 STIP1 HADHA | 4.65e-04 | 1367 | 112 | 13 | 32687490 |
| Pubmed | DHX16 PCNP EXOSC10 RBMXL3 MAP4 MYO6 XAB2 STARD9 AHNAK CYB5R3 HADHA AFF4 PTCD3 | 4.78e-04 | 1371 | 112 | 13 | 36244648 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | PABIR1 MAP4 KIAA1671 BORCS5 STARD9 AHNAK ANKRD11 TNKS1BP1 BOD1L1 PAN3 | 4.79e-04 | 861 | 112 | 10 | 36931259 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | DHX16 EXOSC10 MAP4 MCM4 SMC2 XAB2 KIAA1671 AHNAK STIP1 HADHA AURKB | 4.79e-04 | 1024 | 112 | 11 | 24711643 |
| Pubmed | 5.81e-04 | 441 | 112 | 7 | 31239290 | ||
| Pubmed | 6.08e-04 | 210 | 112 | 5 | 16565220 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | EXOSC10 MAP4 MCM4 SMC2 NCAPH XAB2 AHNAK TNKS1BP1 STIP1 HADHA DIAPH3 TRMT1L PTCD3 | 6.41e-04 | 1415 | 112 | 13 | 28515276 |
| Pubmed | A cell fitness selection model for neuronal survival during development. | 6.64e-04 | 12 | 112 | 2 | 31515492 | |
| Pubmed | 6.64e-04 | 12 | 112 | 2 | 11134352 | ||
| Pubmed | 6.72e-04 | 591 | 112 | 8 | 15231748 | ||
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | COG2 MYO6 YIPF7 NCAPH PTH2R ROPN1L PLEKHM2 CLK1 TRIM17 SLC22A5 DEF6 VWA5B1 | 6.75e-04 | 1242 | 112 | 12 | 30973865 |
| Pubmed | 6.76e-04 | 215 | 112 | 5 | 35973513 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | DHX16 MAP4 MYO6 MCM4 APLP2 SMC2 NCAPH STARD9 CYB5R3 BOD1L1 STIP1 HADHA PTCD3 | 6.84e-04 | 1425 | 112 | 13 | 30948266 |
| Interaction | NAA40 interactions | DHX16 PCNP TTF2 ZNF384 FAM193B EXOSC10 MAP4 MYO6 DLGAP5 MCM4 OCRL NCAPH XAB2 KIAA1671 ALDH1A2 AHNAK CYB5R3 TNKS1BP1 BOD1L1 STIP1 AFF4 DNM2 | 1.06e-08 | 978 | 109 | 22 | int:NAA40 |
| Interaction | CDC5L interactions | DHX16 TTF2 EXOSC10 DOCK8 WRNIP1 MCM4 SMC2 ARID1A NCAPH FAF1 XAB2 ZNF263 AHNAK TNKS1BP1 STIP1 TRMT1L DNM2 AURKB | 7.29e-07 | 855 | 109 | 18 | int:CDC5L |
| Interaction | DCTN1 interactions | TTF2 MAP4 MYO6 DLGAP5 MCM4 SMC2 NCAPH STIP1 JAKMIP1 DIAPH3 DNM2 AURKB | 1.59e-05 | 497 | 109 | 12 | int:DCTN1 |
| Interaction | C9orf78 interactions | FKBP10 COG2 EXOSC10 MAP4 MYO6 WRNIP1 MCM4 OCRL SMC2 XAB2 HADHA DNM2 PTCD3 | 3.05e-05 | 620 | 109 | 13 | int:C9orf78 |
| Cytoband | 12p12 | 4.60e-04 | 13 | 113 | 2 | 12p12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2p23 | 5.21e-04 | 149 | 113 | 4 | chr2p23 | |
| Cytoband | 9p24.3 | 5.36e-04 | 14 | 113 | 2 | 9p24.3 | |
| Coexpression | DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP | 1.21e-06 | 323 | 111 | 10 | M2156 | |
| Coexpression | FAN_EMBRYONIC_CTX_MICROGLIA_1 | 4.48e-06 | 155 | 111 | 7 | M39041 | |
| Coexpression | HOWARD_NK_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_3DY_UP | 1.05e-05 | 68 | 111 | 5 | M41108 | |
| Coexpression | VAN_DEN_BIGGELAAR_PBMC_PREVNAR_9MO_INFANT_STIMULATED_VS_UNSTIMULATED_9MO_UP | 1.72e-05 | 127 | 111 | 6 | M40952 | |
| Coexpression | TRAVAGLINI_LUNG_PROLIFERATING_NK_T_CELL | 1.88e-05 | 129 | 111 | 6 | M41687 | |
| Coexpression | VAN_DEN_BIGGELAAR_PBMC_PREVNAR_9MO_INFANT_STIMULATED_VS_UNSTIMULATED_8MO_UP | 2.47e-05 | 81 | 111 | 5 | M40892 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_EARLY_STALK_CELL | TTF2 TICRR DLGAP5 MCM4 HUNK STOX1 NCAPH STARD9 DIAPH3 CLSPN AURKB | 2.96e-05 | 567 | 111 | 11 | M45692 |
| Coexpression | ZHONG_PFC_MAJOR_TYPES_NPCS | 3.23e-05 | 142 | 111 | 6 | M39078 | |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_LARGE_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | 5.47e-05 | 402 | 111 | 9 | MM454 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_SCHWANN_PRECURSOR_CELL | 6.05e-05 | 232 | 111 | 7 | M45800 | |
| Coexpression | LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM | 7.24e-05 | 417 | 111 | 9 | M39224 | |
| Coexpression | WU_APOPTOSIS_BY_CDKN1A_VIA_TP53 | 7.60e-05 | 53 | 111 | 4 | M10169 | |
| Coexpression | GCNP_SHH_UP_LATE.V1_UP | 1.24e-04 | 181 | 111 | 6 | M2641 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_CYCLING_DEFINITIVE_ERYTHROBLAST | 1.29e-04 | 450 | 111 | 9 | M45747 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPROGFPM | 1.35e-04 | 354 | 111 | 8 | M39061 | |
| Coexpression | GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_12H_UP | 1.48e-04 | 187 | 111 | 6 | M2984 | |
| Coexpression | GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_4H_DN | 1.57e-04 | 189 | 111 | 6 | M4261 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_SST_POS_NEURON_CELL | 2.00e-04 | 375 | 111 | 8 | M45799 | |
| Coexpression | GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_6H_DN | 2.02e-04 | 198 | 111 | 6 | M4264 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C5_PRO_B_CELL | 2.02e-04 | 478 | 111 | 9 | M45785 | |
| Coexpression | GSE30962_PRIMARY_VS_SECONDARY_ACUTE_LCMV_INF_CD8_TCELL_UP | 2.13e-04 | 200 | 111 | 6 | M5041 | |
| Coexpression | GSE24634_TEFF_VS_TCONV_DAY7_IN_CULTURE_UP | 2.13e-04 | 200 | 111 | 6 | M4622 | |
| Coexpression | GSE26495_NAIVE_VS_PD1LOW_CD8_TCELL_DN | 2.13e-04 | 200 | 111 | 6 | M4659 | |
| Coexpression | GSE15750_DAY6_VS_DAY10_TRAF6KO_EFF_CD8_TCELL_UP | 2.13e-04 | 200 | 111 | 6 | M3580 | |
| Coexpression | GSE36476_CTRL_VS_TSST_ACT_40H_MEMORY_CD4_TCELL_OLD_DN | 2.13e-04 | 200 | 111 | 6 | M5300 | |
| Coexpression | GSE2770_UNTREATED_VS_ACT_CD4_TCELL_6H_UP | 2.13e-04 | 200 | 111 | 6 | M6017 | |
| Coexpression | CROONQUIST_NRAS_SIGNALING_DN | 2.25e-04 | 70 | 111 | 4 | M10739 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C2_PROMONOCYTE_LIKE_CELL | 2.40e-04 | 290 | 111 | 7 | M45736 | |
| CoexpressionAtlas | DevelopingGonad_P2_testes_emap-30171_top-relative-expression-ranked_200 | 2.24e-06 | 161 | 112 | 8 | gudmap_developingGonad_P2_testes_200 | |
| CoexpressionAtlas | Fetal Liver, SC.LTSL.FL, IgM- CD24- CD117+ IL7R- CD150+ CD48- AA4.1+ CD43+, Fetal Liver, avg-3 | TICRR DLGAP5 OCRL SMC2 NCAPH ITIH5 SHROOM4 SLC18A2 DIAPH3 CLSPN AURKB | 1.49e-05 | 423 | 112 | 11 | GSM791126_500 |
| CoexpressionAtlas | alpha beta T cells, T.8.TI.B16, 4- 8+ TCR+ 45+, B16 Melanoma Tumor, avg-2 | TICRR DLGAP5 MCM4 SMC2 NCAPH B4GALT5 ITIH5 DIAPH3 CLSPN AURKB | 2.07e-05 | 359 | 112 | 10 | GSM605773_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 2.41e-05 | 291 | 112 | 9 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K3 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_testes_emap-11164_top-relative-expression-ranked_200 | 2.86e-05 | 166 | 112 | 7 | gudmap_developingGonad_e18.5_testes_200 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | TTF2 EXOSC10 MYO6 WRNIP1 SMC2 SLC18A2 ANKRD11 STIP1 TRMT1L PAN3 CLSPN | 3.84e-05 | 469 | 112 | 11 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_k-means-cluster#1_top-relative-expression-ranked_100 | 5.23e-05 | 39 | 112 | 4 | gudmap_developingGonad_e12.5_testes_k1_100 | |
| CoexpressionAtlas | alpha beta T cells, T.8Eff.Sp.OT1.d6.LisOva, CD8+ CD45.1+, Spleen, avg-3 | TICRR DLGAP5 MCM4 SMC2 NCAPH B4GALT5 AHNAK DIAPH3 CLSPN AURKB | 5.38e-05 | 402 | 112 | 10 | GSM605898_500 |
| CoexpressionAtlas | alpha beta T cells, T.8Eff.Sp.OT1.d5.VSVOva, CD8+ CD45.1+, Spleen, avg-3 | TICRR DLGAP5 MCM4 SMC2 NCAPH B4GALT5 AHNAK DIAPH3 CLSPN AURKB | 6.34e-05 | 410 | 112 | 10 | GSM538387_500 |
| CoexpressionAtlas | DevelopingGonad_P2_testes_emap-30171_k-means-cluster#5_top-relative-expression-ranked_200 | 7.03e-05 | 42 | 112 | 4 | gudmap_developingGonad_P2_testes_200_k5 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_testes_emap-8444_top-relative-expression-ranked_200 | 2.28e-04 | 163 | 112 | 6 | gudmap_developingGonad_e16.5_testes_200 | |
| CoexpressionAtlas | alpha beta T cells, preT.DN3-4.Th, Lin-/lo CD25int CD44- CD28+, Thymus, avg-3 | 2.57e-04 | 397 | 112 | 9 | GSM791143_500 | |
| CoexpressionAtlas | alpha beta T cells, T.DPbl.Th, 4+ 8+ TCR-/lo FSChi, Thymus, avg-3 | 2.62e-04 | 398 | 112 | 9 | GSM399397_500 | |
| CoexpressionAtlas | B cells, proB.CLP.BM, CD19- IgM- CD43+ CD24intermediate CD45R- AA4.1+ CD, Bone marrow, avg-2 | 2.67e-04 | 399 | 112 | 9 | GSM538345_500 | |
| CoexpressionAtlas | DevelopingGonad_P2_testes_emap-30171_top-relative-expression-ranked_500 | 3.14e-04 | 408 | 112 | 9 | gudmap_developingGonad_P2_testes_500 | |
| CoexpressionAtlas | B cells, preB.FrC.BM, CD19+ IgM- CD45R+ CD43+ HSA+, Bone marrow, avg-3 | 3.20e-04 | 409 | 112 | 9 | GSM399452_500 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_testes_emap-11164_top-relative-expression-ranked_500 | 3.37e-04 | 412 | 112 | 9 | gudmap_developingGonad_e18.5_testes_500 | |
| CoexpressionAtlas | alpha beta T cells, T.ISP.Th, 4- 8+ TCR-/lo 24hi, Thymus, avg-3 | 3.68e-04 | 417 | 112 | 9 | GSM399403_500 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2-24ahi.Th, TCRd+ Vg2- CD24+, Thymus, avg-2 | 4.02e-04 | 422 | 112 | 9 | GSM476658_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5 | 4.62e-04 | 186 | 112 | 6 | Facebase_RNAseq_e10.5_Mandibular Arch_500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | 4.76e-04 | 432 | 112 | 9 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#3_top-relative-expression-ranked_1000 | 4.92e-04 | 123 | 112 | 5 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k3_1000 | |
| ToppCell | COVID-19-kidney-Proliferating_T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | TTF2 TICRR DLGAP5 SMC2 NCAPH DEF6 JAKMIP1 DIAPH3 CLSPN AURKB | 6.38e-11 | 191 | 113 | 10 | bae388e0e9447d576e68465d73d8313ef6925ffa |
| ToppCell | Dividing_Macrophages-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 5.13e-10 | 169 | 113 | 9 | eb0c993ef2eea73bc4881182520922ce9ae9368f | |
| ToppCell | PBMC-Mild-Lymphocyte-B-Plasmablast-Plasmablast-Developping_Plasmablast|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.73e-09 | 194 | 113 | 9 | 5a519538327029ad2b880ef9647e2ac6ab3961a4 | |
| ToppCell | COVID-19-kidney-Proliferating_T_cell|kidney / Disease (COVID-19 only), tissue and cell type | 1.82e-09 | 195 | 113 | 9 | 7e05e56f8d0a7a052830c7db12b10dace7d10760 | |
| ToppCell | 3'_v3-bone_marrow-Hematopoietic_progenitors-Cycling_pre-Myeloid-1|bone_marrow / Manually curated celltypes from each tissue | 2.08e-09 | 198 | 113 | 9 | 5c92687b853ebb00960adbef6552f9d460bc6886 | |
| ToppCell | Control_saline-Endothelial-Endothelial-FOXM1|Control_saline / Treatment groups by lineage, cell group, cell type | 2.27e-09 | 200 | 113 | 9 | 9bbc7b5561151f6ff65f40b3226271def732e5d9 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.27e-09 | 200 | 113 | 9 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-FOXM1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.25e-09 | 163 | 113 | 8 | 5285318c52aa31c9b22dc2ffff078e32e408604d | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-FOXM1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.23e-08 | 169 | 113 | 8 | e0607af8ae8609d43e26ff2a2cab92650bfcd5b7 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.35e-08 | 171 | 113 | 8 | e3cab55f39879e2bd3e8bda91802181075839bc4 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.35e-08 | 171 | 113 | 8 | 52fdc2a4ec36fb91583b1215362548ceb6740ae1 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4/8-lo-Cycling_T|GI_small-bowel / Manually curated celltypes from each tissue | 1.54e-08 | 174 | 113 | 8 | e4c8da80eca07e4396f57dad212f76c2eca4c1bd | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c03-MKI67|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.84e-08 | 178 | 113 | 8 | dbde3305e0c6a81593fe614e3f2e746b32cc16a7 | |
| ToppCell | Control-Developping_Plasmablast|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.92e-08 | 179 | 113 | 8 | 9383568f78b07b8cca72ece5d15fea209aa54ea9 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.01e-08 | 180 | 113 | 8 | 401df9cddcbca1eb8f0d2687bcacd98e95dc1493 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-FOXM1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.01e-08 | 180 | 113 | 8 | 334e2b1f6eb7d4ece20b1c7b02107863f913237f | |
| ToppCell | droplet-Lung-LUNG-30m-Lymphocytic-Proliferating_NK|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.19e-08 | 182 | 113 | 8 | 0370b395ceb9d4d66f80cf60dd8c28ac60af5c7b | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4/8-lo-Cycling_T|Liver / Manually curated celltypes from each tissue | 2.19e-08 | 182 | 113 | 8 | 81557cdc88777f3bd4e1dd18a760b08fc29122ef | |
| ToppCell | Multiple_Sclerosis-Lymphocyte-T_NK-T_NK_proliferative|Multiple_Sclerosis / Disease, Lineage and Cell Type | 2.82e-08 | 188 | 113 | 8 | 6c05797a5d0635d89ffcf4aca52178687129ccb4 | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 2.82e-08 | 188 | 113 | 8 | f5102e8d95506c25c675094b86162a6a50087b64 | |
| ToppCell | Control-Endothelial-Endothelial-FOXM1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.94e-08 | 189 | 113 | 8 | 1e1499b062d9c647c8f38b0c4e0d871d159be5dd | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_NK-Cycling_NK|lymph-node_spleen / Manually curated celltypes from each tissue | 3.06e-08 | 190 | 113 | 8 | 451eaceb0cb0ec6cfcae00253c0e5c92a168c2f3 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic-lymphocyte-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.18e-08 | 191 | 113 | 8 | 56b45259dfc38bd5ea43b0e3adf47e7e2c043a5d | |
| ToppCell | Severe_COVID-19-Myeloid-proliferating_Myeloid_cells|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 3.45e-08 | 193 | 113 | 8 | 0d85025690c9cd545cba30abc38acbdd6a39b153 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.59e-08 | 194 | 113 | 8 | f39a471293ecc5c5967b00e772b8f48ebc9affbe | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.59e-08 | 194 | 113 | 8 | 17af04acd54dd6a895a966cbb4422de25dc4f1e6 | |
| ToppCell | BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.59e-08 | 194 | 113 | 8 | cb39850e9577015b6b9834e98c36b412bae7d462 | |
| ToppCell | BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.59e-08 | 194 | 113 | 8 | 408597c9aa302a44b112c1d612c21fbb0227a82a | |
| ToppCell | BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.59e-08 | 194 | 113 | 8 | 193cc20fefbd795a4ad59e401a95af47d30603e7 | |
| ToppCell | BAL-Severe-Myeloid-Myeloid|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.59e-08 | 194 | 113 | 8 | 2360b5f995b360419de41612368cab9fb61781a1 | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-B-Pro-B|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.59e-08 | 194 | 113 | 8 | 3590ff471f74a361ee5bf02a58e3104cd3bf7d00 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic-lymphocyte-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.59e-08 | 194 | 113 | 8 | 3c385d93c5fe1a7817813c492f79fdb94d887357 | |
| ToppCell | BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.59e-08 | 194 | 113 | 8 | 903ae11708b0cb24538c6982abd57fe6fa95b8d3 | |
| ToppCell | Control-Lymphoid_T/NK-T/NK_proliferative|Control / Disease group, lineage and cell class | 3.59e-08 | 194 | 113 | 8 | 9bbb124001fba7450f4639f47f9b720a483e7242 | |
| ToppCell | BAL-Severe-Myeloid-Myeloid|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.59e-08 | 194 | 113 | 8 | 58406502a8cbcc3037f79a1b6a683df408297ae5 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.59e-08 | 194 | 113 | 8 | a75ecd0b0a928d4646602f7d16a645f6b3df3af5 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.59e-08 | 194 | 113 | 8 | 17744fd6645cf5a447a01a83f07e8d305c2bcd9c | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic-lymphocyte|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.59e-08 | 194 | 113 | 8 | 635d0e88f9c542a1d9363066c6cdbc6e44db76c1 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.59e-08 | 194 | 113 | 8 | e14f66f7584909621b776292fbd52808273fd2ee | |
| ToppCell | Dividing_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 3.74e-08 | 195 | 113 | 8 | 79ee423df85aa1631b7bdea74eacaf826dfc4a2c | |
| ToppCell | Dividing_cells-Dividing_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 3.74e-08 | 195 | 113 | 8 | 19829760dfcc0edafd2a2bd80f424a45d039af1f | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_B_plasma-Plasmablasts|lymph-node_spleen / Manually curated celltypes from each tissue | 3.74e-08 | 195 | 113 | 8 | 1390728b9a514db534e8bc6dcf72cf51a1065780 | |
| ToppCell | COVID-19-T_cells-Cycling_NK/T_cells|COVID-19 / group, cell type (main and fine annotations) | 3.74e-08 | 195 | 113 | 8 | 764ed100c28d9bc93ee5ecabc5291c8f184d78da | |
| ToppCell | (1)_T_cells-(1)_T_cells_Dividing|(1)_T_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.74e-08 | 195 | 113 | 8 | cf00a0b4f341f0487d5b37810abe2952fdd3f6f2 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.89e-08 | 196 | 113 | 8 | 1d2e0b328eb822db7521b5f5724d4bd17c0bad5f | |
| ToppCell | control-Lymphocytic-Prol._cells|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.89e-08 | 196 | 113 | 8 | 886f7c865b086d6ebb4a1746865c30af6bbed345 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_B-GC_B_(I)|lymph-node_spleen / Manually curated celltypes from each tissue | 3.89e-08 | 196 | 113 | 8 | 32d54c0b487f00c4f8bd765462e484da8a6625c9 | |
| ToppCell | Healthy-T/NK_proliferative|Healthy / disease group, cell group and cell class | 3.89e-08 | 196 | 113 | 8 | 91e44aabb2e85dcc77ddae6f7e000118d45d1de6 | |
| ToppCell | Control-T/NK_proliferative|Control / Disease condition and Cell class | 3.89e-08 | 196 | 113 | 8 | 7b7bc25aef49bfd64f79303a92d527bf8188f7a6 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.05e-08 | 197 | 113 | 8 | 4b13335a43b9d6abc8e542e72440da7feb82fbe6 | |
| ToppCell | Mild_COVID-19-T/NK-proliferating_T/NK|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 4.05e-08 | 197 | 113 | 8 | 5fd52fba2cb6fa67377f873da2ff6ce9c83b0591 | |
| ToppCell | Healthy-T/NK_proliferative|World / disease group, cell group and cell class | 4.05e-08 | 197 | 113 | 8 | e90be1e7e02f736b6aab14010a912b592d6f1e80 | |
| ToppCell | proximal-Hematologic-Proliferating_Macrophage|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.05e-08 | 197 | 113 | 8 | 0b1fa881abbfcc54b322fc27124db3f8947af016 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.05e-08 | 197 | 113 | 8 | d7a9296092153cf66426911fecd810f0c1ef978e | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.05e-08 | 197 | 113 | 8 | dcff23240bb7cb652d7426b29355aa74442ef6fc | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4/8-lo-Cycling_T|blood / Manually curated celltypes from each tissue | 4.05e-08 | 197 | 113 | 8 | 1f7c3d193647b66cce6ea202a40758cd10b8bd12 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic-lymphocyte-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.05e-08 | 197 | 113 | 8 | 21861d8b389fafbdb7c3499684c9b6deee3dbd5e | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.05e-08 | 197 | 113 | 8 | 434a5686a103bb766e0d80038413f0e12ea3981a | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.05e-08 | 197 | 113 | 8 | 8b616cde333bdbc0c591035ad9e4949155866245 | |
| ToppCell | Mild-Lymphoid-T-Proliferating_T|Mild / Condition, Lineage, Cell class and cell subclass | 4.05e-08 | 197 | 113 | 8 | 794517c70089da109f4c6489fe406c0ba6882b76 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.05e-08 | 197 | 113 | 8 | 6bddfa199ca812d9e518eaa02c3d4fb67e9f5b16 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.05e-08 | 197 | 113 | 8 | c0a71a9452febda433bc544e4ac0a79c43dcf13e | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.05e-08 | 197 | 113 | 8 | f34b1e34f1f0694564031077172c890b233ce8b7 | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4/8-lo|blood / Manually curated celltypes from each tissue | 4.05e-08 | 197 | 113 | 8 | acd678586aa0e4375bc8fbcdaa1a796c8dd23885 | |
| ToppCell | proximal-3-Hematologic-Proliferating_Macrophage|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.05e-08 | 197 | 113 | 8 | 0dd9058aa19d1268ebba9a65555870224b5a5978 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4/8-lo-Cycling_T|lymph-node_spleen / Manually curated celltypes from each tissue | 4.05e-08 | 197 | 113 | 8 | aca6cbff7391ff550061bb7daa67fc5f6585806a | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic-lymphocyte|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.05e-08 | 197 | 113 | 8 | ffb004c37cdd26cb7cdcd80f769a2eded65416dc | |
| ToppCell | proximal-Hematologic-Proliferating_Macrophage-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.05e-08 | 197 | 113 | 8 | 9243617b307acf3df40d93c41cd8d4788699a7ea | |
| ToppCell | Healthy_donor-T/NK_proliferative|Healthy_donor / disease group, cell group and cell class (v2) | 4.05e-08 | 197 | 113 | 8 | b6bbf87e5823fa66b4cad6a7be4f777356887b59 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_NK-Cycling_NK|lymph-node_spleen / Manually curated celltypes from each tissue | 4.21e-08 | 198 | 113 | 8 | b2868a897dd96494cf1829c30e0ce508f52efdf3 | |
| ToppCell | COVID-19_Moderate-T/NK_proliferative|COVID-19_Moderate / disease group, cell group and cell class | 4.21e-08 | 198 | 113 | 8 | 166c000fb0e19602ffdd8bf2b2f19be2c6df96a6 | |
| ToppCell | severe-Lymphocytic-Prol._cells|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.21e-08 | 198 | 113 | 8 | 4d8591eabb543ed789f963b507a07c560c76a7c9 | |
| ToppCell | COVID-19_Moderate-T/NK_proliferative|World / disease group, cell group and cell class | 4.21e-08 | 198 | 113 | 8 | bf0131fbca6032e1aab4aa807f8c1d3be689cb7f | |
| ToppCell | (3)_DC_Monocyte_Dividing|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 4.21e-08 | 198 | 113 | 8 | e2b89f6d7c0007ccab62495cd543fe0e5513a9a4 | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-myeloid-myeloid_granulocytic-granulocyte|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.21e-08 | 198 | 113 | 8 | 2e669da80363163b806f23a645474d482797ae5d | |
| ToppCell | medial-2-Hematologic-Proliferating_Macrophage|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.21e-08 | 198 | 113 | 8 | 64a2bcf5a9ba66a4fe08fbde33f1886c136cde8f | |
| ToppCell | medial-Hematologic-Proliferating_Macrophage-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.21e-08 | 198 | 113 | 8 | fcc14ac3eb5088b9d6cd6af5a34dee5b81c0ece8 | |
| ToppCell | normal_Lymph_Node-T/NK_cells-Undetermined|T/NK_cells / Location, Cell class and cell subclass | 4.21e-08 | 198 | 113 | 8 | 47d572b9db2843aeb2079f33a852babf67270be4 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Dividing_Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.21e-08 | 198 | 113 | 8 | f088badb90c6c2d916195f5649eda102119c9ac6 | |
| ToppCell | Sepsis-Bac-SEP-Lymphocyte-B-Plasmablast|Bac-SEP / Disease, condition lineage and cell class | 4.21e-08 | 198 | 113 | 8 | 614055c11d1dd2f3f2b8783ec35a8f4570cad161 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-Plasmablast-Plasmablast-Developping_Plasmablast|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.21e-08 | 198 | 113 | 8 | 2d8d4eb21b4fe3cc178b3518b3ea39c2d9650f24 | |
| ToppCell | medial-Hematologic-Proliferating_Macrophage|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.21e-08 | 198 | 113 | 8 | da6963184c32761c896a9b91a5321ad84b583736 | |
| ToppCell | mild_COVID-19-T/NK_proliferative|World / disease group, cell group and cell class (v2) | 4.38e-08 | 199 | 113 | 8 | d44cc74d7171d96add61dae821daf774b17d4c69 | |
| ToppCell | Leuk-UTI-Lymphocyte-T_NK-T_NK_proliferative|Leuk-UTI / Disease, Lineage and Cell Type | 4.38e-08 | 199 | 113 | 8 | 87113d398585076ece86b9098781e817f8ca241b | |
| ToppCell | VE-cycling|VE / Condition, Cell_class and T cell subcluster | 4.38e-08 | 199 | 113 | 8 | 47c47ebc318a0b98841ca2656837bbd068899559 | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-Proliferating_Epithelial_cells|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 4.38e-08 | 199 | 113 | 8 | 4fcf5bec207e4384fd73c5e8801a7e414e3ee7b0 | |
| ToppCell | Mild/Remission-Developping_Plasmablast|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 4.38e-08 | 199 | 113 | 8 | 58c772ec763109a4009f52424fbb214fc23d0c09 | |
| ToppCell | Healthy_donor-T/NK_proliferative|World / disease group, cell group and cell class (v2) | 4.38e-08 | 199 | 113 | 8 | 1311dfd74b991f48b047a439f04f9bf7dfaa0e7a | |
| ToppCell | Megakaryocytic-erythropoietic-Erythro-cells-Polychromatic_Erythroblast|Megakaryocytic-erythropoietic / Lineage, cell class and subclass | 4.38e-08 | 199 | 113 | 8 | fa698f00d2dad74d28b4696c8c23dce70f123e52 | |
| ToppCell | VE-cycling-|VE / Condition, Cell_class and T cell subcluster | 4.38e-08 | 199 | 113 | 8 | c0a67149a19b65b3069dbc5261d81f658e6e39a2 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-FOXM1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.38e-08 | 199 | 113 | 8 | 98575fcce726589e93fbb4df1aab03e57cb56076 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-FOXM1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.38e-08 | 199 | 113 | 8 | be2276c9a1994579ba1d2998b49bf549c1324d44 | |
| ToppCell | Mild/Remission-Developping_Plasmablast|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 4.38e-08 | 199 | 113 | 8 | 1dda6116de639140c2d6f5012b7ab9ad0f737ae1 | |
| ToppCell | normal_Lymph_Node-T/NK_cells-Undetermined|normal_Lymph_Node / Location, Cell class and cell subclass | 4.38e-08 | 199 | 113 | 8 | cefcfe639a3396bccf2354ca605a1e18b964fbf2 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-FOXM1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.55e-08 | 200 | 113 | 8 | 4cfe08878a6981bf7b3567f9e82192d8f060ddde | |
| ToppCell | Control-Control-Lymphocyte-T/NK-T/NK_proliferative|Control / Disease, condition lineage and cell class | 4.55e-08 | 200 | 113 | 8 | 6cf63dd57f6bc0c42e7182322dd24ff9afbe9186 | |
| ToppCell | Biopsy_IPF-Epithelial-Proliferating_Epithelial_cells|Biopsy_IPF / Sample group, Lineage and Cell type | 4.55e-08 | 200 | 113 | 8 | 63c5402f050fdb12abab3c8b7f33d4914ae26b9b | |
| ToppCell | healthy_donor-Lymphocytic-Proliferative_Lymphocyte|healthy_donor / Disease condition, Lineage, Cell class and subclass | 4.55e-08 | 200 | 113 | 8 | e4eb915c29909cf8535a3603c68976545c05e54b | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_B_plasma-Plasmablasts|lymph-node_spleen / Manually curated celltypes from each tissue | 4.55e-08 | 200 | 113 | 8 | b0d708715f09ec1f67fdef3b100a91c8ff2747a7 | |
| ToppCell | Biopsy_Control_(H.)-Immune-Proliferating_Macrophages|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 4.55e-08 | 200 | 113 | 8 | ce9fad55f779afd3d6c5a9c5a15e2d9f548b7c7e | |
| Computational | Neighborhood of CDC20 | 2.24e-05 | 56 | 66 | 5 | GNF2_CDC20 | |
| Computational | Neighborhood of HMMR | 1.90e-04 | 47 | 66 | 4 | GNF2_HMMR | |
| Computational | Neighborhood of CCNB2 | 4.01e-04 | 57 | 66 | 4 | GNF2_CCNB2 | |
| Computational | Neighborhood of BUB1 | 5.20e-04 | 26 | 66 | 3 | GNF2_BUB1 | |
| Disease | Dent disease | 1.30e-05 | 2 | 107 | 2 | cv:C0878681 | |
| Disease | Dent disease (is_implicated_in) | 1.30e-05 | 2 | 107 | 2 | DOID:0050699 (is_implicated_in) | |
| Disease | developmental and epileptic encephalopathy (implicated_via_orthology) | 9.90e-04 | 13 | 107 | 2 | DOID:0112202 (implicated_via_orthology) | |
| Disease | cortical surface area measurement | DHX16 TICRR KIF6 RNLS NBEAL1 STOX1 FAF1 ITIH5 ALDH1A2 DMRT2 VPS35L SLC4A10 DIAPH3 | 1.17e-03 | 1345 | 107 | 13 | EFO_0010736 |
| Disease | sporadic amyotrophic lateral sclerosis | 1.72e-03 | 140 | 107 | 4 | EFO_0001357 | |
| Disease | hippocampal tail volume | 2.14e-03 | 19 | 107 | 2 | EFO_0009398 | |
| Disease | non-melanoma skin carcinoma | 2.84e-03 | 265 | 107 | 5 | EFO_0009260 | |
| Disease | eosinophil count | DHX16 FKBP10 PLB1 POU2F2 MCM4 DNAJC27 PLPPR3 STOX1 NCAPH ALDH1A2 ANKRD11 ELF1 TNKS1BP1 | 2.85e-03 | 1488 | 107 | 13 | EFO_0004842 |
| Disease | complement factor H-like 1 protein measurement | 2.87e-03 | 22 | 107 | 2 | EFO_0600092 | |
| Disease | spermatogenic failure (is_implicated_in) | 3.14e-03 | 23 | 107 | 2 | DOID:0111910 (is_implicated_in) | |
| Disease | Epilepsy, Cryptogenic | 3.34e-03 | 82 | 107 | 3 | C0086237 | |
| Disease | Awakening Epilepsy | 3.34e-03 | 82 | 107 | 3 | C0751111 | |
| Disease | Aura | 3.34e-03 | 82 | 107 | 3 | C0236018 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MAMLKLLRPSLSEGP | 946 | Q8IZF5 | |
| FMMSKLPLENPVLLD | 31 | P55773 | |
| LNMDSPGPMLDEKRI | 106 | P32519 | |
| ARPREKLLGDGDLMM | 1566 | Q6UB99 | |
| PAELRSFNMPSLDKM | 606 | Q96RT6 | |
| IEMPGEVKADPAALM | 6 | O94788 | |
| GEDMPPDLLLQMLKL | 136 | A6NHR8 | |
| MPALLERPKLSNAMA | 1 | Q13227 | |
| ISMPDFDLNLKGPKM | 3671 | Q09666 | |
| SLIQPIDGMKMEKSP | 111 | O95813 | |
| SLLAKAVDPRHPNMM | 271 | Q9NSV4 | |
| SGRKMAELPVDPMLS | 811 | O60231 | |
| ERLPSMKGPIDINMS | 116 | O43286 | |
| KMAPNPLLDTMRPDS | 411 | Q2TAZ0 | |
| RMFSPMEEKELLSPL | 691 | Q9UHB7 | |
| EHLAMMERILGPLPK | 386 | P49759 | |
| PPLELLKELMNMAVE | 416 | Q6ZS30 | |
| PMLQVIRAIMKDPDD | 186 | P00387 | |
| GPPEKRITATMDDML | 1901 | O14497 | |
| VDPMLTPEERHLNKM | 731 | Q06481 | |
| MIKLQESPEDMPAGQ | 351 | P33991 | |
| RSPLLSPDMKNLMLE | 71 | Q9Y215 | |
| IMNELMGKRFSPKDP | 396 | Q96EY7 | |
| EERPPAQALEIMMGL | 231 | P27816 | |
| RASPIKMDLAPSKDM | 356 | P27816 | |
| EKMLSKPEMGSPRAL | 356 | Q9BY89 | |
| MKLRGPVPRMDGLEE | 621 | Q86UX2 | |
| MEANMPKRKEPGRSL | 1 | Q9NZQ0 | |
| MDDIPHILKGCMPDR | 276 | Q53G44 | |
| VLRMPMNAALGEPSK | 2101 | Q5SZK8 | |
| MKTEVPGPRSQELMK | 46 | P80404 | |
| GDMMKDLPILKSDDP | 456 | Q5H9U9 | |
| PLGERQSESMPDRKM | 461 | Q53TS8 | |
| PEAKMRMKNIGRDTP | 126 | Q8WW12 | |
| AELPEDPSMMGRLGK | 611 | O43526 | |
| LGIQPIPMMDRDKKD | 696 | Q9Y233 | |
| MGAPEIRMSKPLEAE | 6 | P09086 | |
| MAVPLMPDQQEEKLR | 626 | Q6ZMV9 | |
| KRELPPGIGDMVELM | 261 | Q96N16 | |
| MAQEKMELDLELPPG | 1 | Q96E09 | |
| MGNRGMEELIPLVNK | 1 | P50570 | |
| LGMLEERLVPMGSKA | 236 | Q58A45 | |
| KKSGDMTLIPEQEPM | 1106 | Q8NFC6 | |
| MMLKIAEELPKEPQG | 536 | Q01780 | |
| RLMPGQDPEKTIGDM | 536 | Q96AY3 | |
| NIPGISPDMMKLIIE | 81 | Q6JEL2 | |
| EPPDAKMLQMVLQGS | 1966 | Q8NF50 | |
| QDMMPSKLEGSLVLP | 391 | Q9Y5R5 | |
| PDFMPKLVKNLLGEM | 111 | Q96PV7 | |
| GLKQDIPKMVPAEMS | 486 | A2CJ06 | |
| MEDPLEMERSPQLRK | 66 | Q8WWM9 | |
| LAMDVMKPRRNDPLL | 651 | P51795 | |
| GIPHKEDPLMLDMVR | 546 | P57058 | |
| MLPEGERLEPFSMKP | 176 | Q969J3 | |
| MNPDGVLSKMENLPE | 281 | Q15398 | |
| APCGPKEQLSMEMIL | 251 | Q9P2S6 | |
| QMNRLMHPIEPGDKR | 546 | Q9H4E7 | |
| MKPENLLCMGPELVK | 126 | P20794 | |
| LTDMPQMRMELERPG | 251 | P02671 | |
| QRLPKMVGVPAALDM | 186 | P40939 | |
| NMEIMPEGSLLIKDP | 71 | Q17R55 | |
| ALRKSPMMPENAENE | 316 | Q9UNN5 | |
| MEKSRMNLPKGPDTL | 1 | Q14746 | |
| PLPDTIDQMLRVKGM | 516 | O76082 | |
| GRKSQKMSEPIAEPM | 836 | Q05469 | |
| PGLLIPEMKDTSMER | 391 | Q8IWE5 | |
| PEMKDTSMERLGQPL | 396 | Q8IWE5 | |
| RMLESVMKEIPPGAL | 261 | Q8TB92 | |
| LEMDLKPDAIGMPLQ | 266 | A5PLK6 | |
| PGQSGMDDMKLLEQR | 761 | Q9HCS7 | |
| DPMGVRTDAPLMQFK | 671 | Q7Z2T5 | |
| DPAMRLILEQMQKDP | 501 | P31948 | |
| GPLIKLEMMISEPCQ | 756 | Q14DG7 | |
| MELQDPKMNGALPSD | 1 | Q8WUX1 | |
| KDLKSEPNPLRSMMD | 71 | P0DKX4 | |
| GEICPALLKRNMMPN | 906 | Q9ULL8 | |
| PDELRPMLAQNLMLK | 646 | Q8NEZ3 | |
| KRDIPDKAPQALMMD | 3711 | Q9P2P6 | |
| RMMEPAGEKDEPLSV | 311 | Q6P1J6 | |
| EGMEMKGPLREPCAL | 16 | Q01968 | |
| DGDIRTMCPLLSMKP | 411 | Q15003 | |
| KPRLPLASMDENAMD | 891 | Q9HAW4 | |
| PPEMIEGRMHNEKVD | 241 | Q96GD4 | |
| DLSLMSPELKMGKPA | 891 | Q9BXU1 | |
| QEMLKEMPLQDPRSR | 36 | Q6UW78 | |
| LTGMKLENPADPQLM | 831 | Q86UP3 | |
| KKRMLESGLPEMNDP | 196 | Q8TF68 | |
| RMEGMLFLPVEAGKE | 301 | Q7Z2Z1 | |
| EMSLFLQGPEEMLPL | 11 | Q5VV52 | |
| PKMINIDGKMRPSES | 756 | Q7Z3J2 | |
| MMEADRPEKLFIGGL | 1 | Q8N7X1 | |
| RGDPLPVKDRMEMPT | 51 | Q96C74 | |
| GRFVMDPAEMEPSLK | 856 | Q9UPX0 | |
| VDLLAPRSPMAKENM | 356 | Q6T4P5 | |
| LRPLSSPIEGMVMKE | 86 | Q5VYX0 | |
| MAEMEKEGRPPENKR | 1 | A7XYQ1 | |
| ENKRMLPSDESRLMP | 201 | Q6ZVD7 | |
| MEIKDQGAQMEPLLP | 1 | Q6U841 | |
| PLAELPSARKMNMLA | 71 | Q9C0C2 | |
| LVMPKEMVPLGDSNS | 841 | A0A0J9YWL9 | |
| GSPLMDMLQLAEEPV | 431 | Q6XQN6 | |
| QEMDPENMLLPAGLR | 36 | Q9NZQ9 | |
| GDDILMEKPSRPMES | 521 | P49190 | |
| MKPPEILSMIEEAAG | 156 | O95347 | |
| GPLQMLQDMKEPLSR | 246 | Q9Y577 | |
| MLQGKPLADTMRPDT | 221 | Q96S55 | |
| PKEMMDRDQDCLLPV | 1266 | Q92508 | |
| PMKPVDGSIMNETDL | 136 | Q8N8F6 | |
| RSPPAKEEKMAILMD | 471 | Q05940 | |
| AMPLAQGLMDKDERV | 956 | Q6ZQQ6 | |
| DRFGPNKMMRLDSSP | 936 | O60293 | |
| LLMVGEDMQPKDPAA | 216 | A6NL46 | |
| PEMMEKDLSSGLVPK | 171 | Q9UNY4 | |
| SAELLMEGERLQPKM | 511 | Q5TIE3 | |
| LSLFPPEGNMEDKEM | 196 | O14978 | |
| KPPILLVAGKDDMEM | 1221 | Q9UM54 |